File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1039/9781788016452-00120
- Scopus: eid_2-s2.0-85065126934
Supplementary
-
Citations:
- Scopus: 0
- Appears in Collections:
Book Chapter: Anticancer Gold Compounds
| Title | Anticancer Gold Compounds |
|---|---|
| Authors | |
| Issue Date | 2019 |
| Publisher | Cambridge |
| Citation | Anticancer Gold Compounds. In Casini, A, Vessières, A. and Meier-Menches, SM (Eds.), Metal-based Anticancer Agents, p. 120-142. Royal Society of Chemistry: Cambridge , 2019 How to Cite? |
| Abstract | The use of gold in medicine has a long history that dates back to ancient times. In modern medicine, gold compounds have been applied as anti-inflammatory agents for the treatment of rheumatoid arthritis. Recently, gold complexes have gained increasing attention in the design of metal-based anticancer chemotherapeutics. Gold(i) and gold(iii) ions are often unstable or reactive via redox reactions under physiological conditions. By judicious selection of coordination ligands, gold(i) and gold(iii) complexes that are stable under physiological conditions can be prepared and harnessed for anticancer applications. In this chapter, our current understanding on the anticancer properties of gold compounds and the approaches to identify their molecular targets and improve anticancer efficiency are reviewed. |
| Persistent Identifier | http://hdl.handle.net/10722/275676 |
| ISBN | |
| Series/Report no. | RSC metallobiology series; 14 |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Hu, D | - |
| dc.contributor.author | Lok, CN | - |
| dc.contributor.author | Che, CM | - |
| dc.date.accessioned | 2019-09-10T02:47:23Z | - |
| dc.date.available | 2019-09-10T02:47:23Z | - |
| dc.date.issued | 2019 | - |
| dc.identifier.citation | Anticancer Gold Compounds. In Casini, A, Vessières, A. and Meier-Menches, SM (Eds.), Metal-based Anticancer Agents, p. 120-142. Royal Society of Chemistry: Cambridge , 2019 | - |
| dc.identifier.isbn | 9781788014069 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/275676 | - |
| dc.description.abstract | The use of gold in medicine has a long history that dates back to ancient times. In modern medicine, gold compounds have been applied as anti-inflammatory agents for the treatment of rheumatoid arthritis. Recently, gold complexes have gained increasing attention in the design of metal-based anticancer chemotherapeutics. Gold(i) and gold(iii) ions are often unstable or reactive via redox reactions under physiological conditions. By judicious selection of coordination ligands, gold(i) and gold(iii) complexes that are stable under physiological conditions can be prepared and harnessed for anticancer applications. In this chapter, our current understanding on the anticancer properties of gold compounds and the approaches to identify their molecular targets and improve anticancer efficiency are reviewed. | - |
| dc.language | eng | - |
| dc.publisher | Cambridge | - |
| dc.relation.ispartof | Metal-based Anticancer Agents | - |
| dc.relation.ispartofseries | RSC metallobiology series; 14 | - |
| dc.title | Anticancer Gold Compounds | - |
| dc.type | Book_Chapter | - |
| dc.identifier.email | Hu, D: hudi@hku.hk | - |
| dc.identifier.email | Lok, CN: cnlok@hkucc.hku.hk | - |
| dc.identifier.email | Che, CM: chemhead@hku.hk | - |
| dc.identifier.authority | Lok, CN=rp00752 | - |
| dc.identifier.authority | Che, CM=rp00670 | - |
| dc.description.nature | link_to_subscribed_fulltext | - |
| dc.identifier.doi | 10.1039/9781788016452-00120 | - |
| dc.identifier.scopus | eid_2-s2.0-85065126934 | - |
| dc.identifier.hkuros | 303756 | - |
| dc.identifier.spage | 120 | - |
| dc.identifier.epage | 142 | - |
| dc.publisher.place | Royal Society of Chemistry | - |